At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
Introvision: mental and emotional self-regulationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Migraine With Introvision, a Method of Mental Self-regulation - IntroMig: Randomised Waiting-list Control Study
In Brief
A clinical study evaluating Introvision: mental and emotional self-regulation for Migraine and Chronic Migraine. Completed, enrolled 72 participants across 1 site.
Detailed Summary
To evaluate the effect of Introvision, a mental and emotional self-regulation-technique developed by Angelika C. Wager, as migraine preventative compared to a waiting list group.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine, Chronic Migraine
CountriesGermany
CollaboratorsUniversity of Hamburg-Eppendorf, Introvision e.V
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartSep 2017
First PostedApr 2018
Primary CompletionSep 2019
Study CompletionJul 2020
TodayJul 2026
First PostedApr 25, 2018
Enrollment StartSep 20, 2017
Primary CompletionSep 11, 2019
Study CompletionJul 19, 2020
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 8.2 years ago
Interventions
Introvision: mental and emotional self-regulationbehavioral
Participants learn Introvision